Detalhe da pesquisa
1.
Bortezomib-based therapy is effective and well tolerated in frontline and multiply pre-treated Waldenström macroglobulinaemia including BTKi failures: A real-world analysis.
EJHaem
; 3(4): 1330-1334, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36467794